Experimental Hematology
Volume 36, Issue 7 , Pages 799-806 , July 2008

Transcriptional regulation of bone marrow thrombopoietin by platelet proteins

  • Bryan McIntosh
  • ,
  • Kenneth Kaushansky

      Affiliations

    • Corresponding Author InformationOffprint requests to: Kenneth Kaushansky, M.D., Department of Medicine, University of California, San Diego, 9500 Gilman Drive, San Diego, CA 92103-8811

Received 28 November 2007 ,Revised 19 February 2008 ,Accepted 21 February 2008.

References 

  1. Gurney AL, Carver-Moore K, de Sauvage FJ, Moore MW. Thrombocytopenia in c-mpl-deficient mice. Science. 1994;265(5177):1445–1447
  2. de Sauvage FJ, Carver-Moore K, Luoh SM, et al. Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J Exp Med. 1996;183:651–656
  3. Ballmaier M, Germeshausen M, Schulze H, et al. c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia. Blood. 2001;97:139–146
  4. Kuter DJ, Rosenberg RD. The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. Blood. 1995;85:2720–2730
  5. Fielder PJ, Gurney AL, Stefanich E, et al. Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets. Blood. 1996;87:2154–2161
  6. Stoffel R, Wiestner A, Skoda R. Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets. Blood. 1996;87:567–573
  7. Lok S, Kaushansky K, Holly RD, et al. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature. 1994;369(6481):565–568
  8. McCarty JM, Sprugel KH, Fox NE, Sabath DE, Kaushansky K. Murine thrombopoietin mRNA levels are modulated by platelet count. Blood. 1995;86:3668–3675
  9. Sungaran R, Markovic B, Chong BH. Localization and regulation of thrombopoietin mRNa expression in human kidney, liver, bone marrow, and spleen using in situ hybridization. Blood. 1997;89:101–107
  10. Kacena MA, Nelson T, Clough ME, et al. Megakaryocyte-mediated inhibition of osteoclast development. Bone. 2006;39:991–999
  11. Sungaran R, Chisholm OT, Markovic B, et al. The role of platelet alpha-granular proteins in the regulation of thrombopoietin messenger RNA expression in human bone marrow stromal cells. Blood. 2000;95:3094–3101
  12. Nakano T, Kodama H, Honjo T. Generation of lymphohematopoietic cells from embryonic stem cells in culture. Science. 1994;265(5175):1098–1101
  13. Bernhard HP, Darlington GJ, Ruddle FH. Expression of liver phenotypes in cultured mouse hepatoma cells: synthesis and secretion of serum albumin. Dev Biol. 1973;35:83–96
  14. Feugier P, Li N, Jo D, et al. Osteopetrotic mouse stroma with thrombopoietin, c-kit ligand, and flk-2 ligand supports long-term mobilized CD34+ hematopoiesis in vitro. Stem Cells Dev. 2005;14:505–516
  15. Akiyama Y. TFSEARCH: searching transcription factor binding sites. Available at: http://www.rwcp.or.jp/papia/. Accessed November 2006.
  16. Heinemeyer T, Wingender E, Reuter I, et al. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucl Acids Res. 1998;26:362–367
  17. Franklin AJ, Jetton TL, Shelton KD, Magnuson MA. BZP, a novel serum-responsive zinc finger protein that inhibits gene transcription. Mol Cell Biol. 1994;14:6773–6788
  18. Jethanandani P, Kramer RH. {alpha}7 Integrin expression is negatively regulated by {delta}EF1 during skeletal myogenesis. J Biol Chem. 2005;280:36037–36046
  19. Shirakihara T, Saitoh M, Miyazono K. Differential regulation of epithelial and mesenchymal markers by {delta}EF1 proteins in epithelial mesenchymal transition induced by TGF-beta. Mol Biol Cell. 2007;18:3533–3544
  20. van Grunsven LA, Michiels C, Van de Putte T, et al. Interaction between Smad-interacting protein-1 and the corepressor C-terminal binding protein is dispensable for transcriptional repression of E-cadherin. J Biol Chem. 2003;278:26135–26145
  21. Postigo AA. Opposing functions of ZEB proteins in the regulation of the TGFbeta/BMP signaling pathway. EMBO J. 2003;22:2443–2452
  22. Ponticos M, Partridge T, Black CM, Abraham DJ, Bou-Gharios G. Regulation of collagen type I in vascular smooth muscle cells by competition between Nkx2.5 and deltaEF1/ZEB1. Mol Cell Biol. 2004;24:6151–6161
  23. Postigo AA, Depp JL, Taylor JJ, Kroll KL. Regulation of Smad signaling through a differential recruitment of coactivators and corepressors by ZEB proteins. EMBO J. 2003;22:2453–2462
  24. van Grunsven LA, Schellens A, Huylebroeck D, Verschueren K. SIP1 (Smad interacting protein 1) and deltaEF1 (delta-crystallin enhancer binding factor) are structurally similar transcriptional repressors. J Bone Joint Surg. 2001;83-A(Suppl 1; Pt 1):S40–S47
  25. Sekido R, Murai K, Funahashi J, et al. The delta-crystallin enhancer-binding protein delta EF1 is a repressor of E2-box-mediated gene activation. Mol Cell Biol. 1994;14:5692–5700
  26. Murray D, Precht P, Balakir R, Horton WE. The transcription factor deltaEF1 is inversely expressed with type II collagen mRNA and can repress Col2a1 promoter activity in transfected chondrocytes. J Biol Chem. 2000;275:3610–3618
  27. Sekido R, Murai K, Kamachi Y, Kondoh H. Two mechanisms in the action of repressor deltaEF1: binding site competition with an activator and active repression. Genes Cells. 1997;2:771–783
  28. Terraz C, Toman D, Delauche M, Ronco P, Rossert J. delta Ef1 binds to a far upstream sequence of the mouse pro-alpha 1(I) collagen gene and represses its expression in osteoblasts. J Biol Chem. 2001;276:37011–37019
  29. Sooy K, Demay MB. Transcriptional repression of the rat osteocalcin gene by {delta}EF1. Endocrinology. 2002;143:3370–3375
  30. Calvi LM, Adams GB, Weibrecht KW, et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature. 2003;425(6960):841–846
  31. Zhang J, Niu C, Ye L, et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature. 2003;425(6960):836–841
  32. Solar GP, Kerr WG, Zeigler FC, et al. Role of c-mpl in early hematopoiesis. Blood. 1998;92:4–10
  33. Sitnicka E, Lin N, Priestley GV, et al. The effect of thrombopoietin on the proliferation and differentiation of murine hematopoietic stem cells. Blood. 1996;87:4998–5005
  34. Boyce BF, Xing L. Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res Ther. 2007;9(Suppl 1):S1
  35. Kacena MA, Gundberg CM, Horowitz MC. A reciprocal regulatory interaction between megakaryocytes, bone cells, and hematopoietic stem cells. Bone. 2006;39:978–984
  36. Chagraoui H, Sabri S, Capron C, et al. Expression of osteoprotegerin mRNA and protein in murine megakaryocytes. Exp Hematol. 2003;31:1081–1088
  37. Bord S, Vedi S, Beavan SR, Horner A, Compston JE. Megakaryocyte population in human bone marrow increases with estrogen treatment: a role in bone remodeling?. Bone. 2000;27:397–401
  38. Bord S, Frith E, Ireland DC, et al. Synthesis of osteoprotegerin and RANKL by megakaryocytes is modulated by oestrogen. Br J Haematol. 2004;126:244–251
  39. Bord S, Frith E, Ireland DC, et al. Megakaryocytes modulate osteoblast synthesis of type-l collagen, osteoprotegerin, and RANKL. Bone. 2005;36:812–819
  40. Miao D, Murant S, Scutt N, Genever P, Scutt A. Megakaryocyte-bone marrow stromal cell aggregates demonstrate increased colony formation and alkaline phosphatase expression in vitro. Tissue Eng. 2004;10:807–817
  41. Kacena MA, Shivdasani RA, Wilson K, et al. Megakaryocyte-osteoblast interaction revealed in mice deficient in transcription factors GATA-1 and NF-E2. J Bone Miner Res. 2004;19:652–660
  42. Thiede M, Smock S, Petersen D, et al. Presence of messenger ribonucleic acid encoding osteocalcin, a marker of bone turnover, in bone marrow megakaryocytes and peripheral blood platelets. Endocrinology. 1994;135:929–937
  43. Alemany J, Zelenka P, Serrano J, de Pablo F. Insulin-like growth factor I and insulin regulate delta-crystallin gene expression in developing lens. J Biol Chem. 1989;264:17559–17563

PII: S0301-472X(08)00097-0

doi: 10.1016/j.exphem.2008.02.012

Experimental Hematology
Volume 36, Issue 7 , Pages 799-806 , July 2008